The stock of Exova Group Plc (LON:EXO) is a huge mover today! The stock increased 5.41% or GBX 10 on November 18, hitting GBX 195. About 1,075 shares traded hands. Exova Group Plc (LON:EXO) has risen 15.63% since April 20, 2016 and is uptrending. It has outperformed by 11.19% the S&P500.
The move comes after 6 months negative chart setup for the GBX 462.71M company. It was reported on Nov, 18 by Barchart.com. We have GBX 171.60 PT which if reached, will make LON:EXO worth GBX 55.53M less.
Exova Group Plc (LON:EXO) Ratings Coverage
Out of 6 analysts covering Exova Group Plc (LON:EXO), 6 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. Exova Group Plc has been the topic of 23 analyst reports since August 24, 2015 according to StockzIntelligence Inc. Shore Capital maintained the stock with “Buy” rating in Tuesday, February 23 report. On Wednesday, August 31 the stock rating was maintained by Peel Hunt with “Add”. The firm earned “Overweight” rating on Friday, March 4 by Barclays Capital. The firm has “Buy” rating by Shore Capital given on Wednesday, August 31. The rating was initiated by Shore Capital on Friday, January 8 with “Buy”. The stock of Exova Group Plc (LON:EXO) earned “Overweight” rating by Barclays Capital on Tuesday, September 1. The stock of Exova Group Plc (LON:EXO) has “Buy” rating given on Thursday, March 3 by Shore Capital. On Wednesday, November 11 the stock rating was maintained by Peel Hunt with “Hold”. Peel Hunt maintained it with “Add” rating and GBX 210 target price in Wednesday, September 21 report. The rating was maintained by Investec on Thursday, February 11 with “Buy”.
Another recent and important Exova Group Plc (LON:EXO) news was published by Businesswire.com which published an article titled: “Exova acquires Environmental Evaluation” on February 09, 2015.
Exova Group plc is a United Kingdom well-known provider of testing and advisory services. The company has a market cap of 462.71 million GBP. The Firm is a laboratory testing firm operating approximately 140 laboratories and offices in over 30 countries throughout Europe, the Americas, the Middle East and Asia/Asia Pacific. It has a 23.89 P/E ratio. The Company’s divisions include Europe, Americas and Rest of World.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.